Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Joseph Glorioso
University of Pittsburgh at Pittsburgh, Department: Genetics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Oncorus, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
This grant is funding animal research that is evaluating and/or developing intellectual property owned by, or optioned or licensed to, Oncorus, Inc. The investigator consults for the company (cash remuneration greater than $5,000/12-month period) and holds equity in this non-publicly traded company.
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
Glioblastoma multiforme (GBM) is a lethal form of brain cancer affecting the lives of approximately 10,000 Americans annually. GBMs fail to respond to available treatments. Oncolytic viruses are promising for their lytic destruction of cancer in clinical trials, however durable treatment will require the induction of active innate and adaptive anti-tumor immunity. We propose to enhance the anti-cancer efficacy of a newly developed herpesvirus oncolytic vector by ?arming? with genes that activate the immune system and improve their therapeutic potency.
Filed on June 25, 2019.
Tell us what you know about Joseph Glorioso's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Joseph Glorioso filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Joseph Glorioso | University of Pittsburgh at Pittsburgh | Conflict of Interest | Oncorus, Inc. | $100,000 - $149,999 |
| Joseph C. Glorioso | University of Pittsburgh at Pittsburgh | Conflict of Interest | Oncorus | $100,000 - $149,999 |
| Joseph C. Glorioso | University of Pittsburgh at Pittsburgh | Conflict of Interest | Oncorus | $5,000 - $9,999 |
| Joseph C. Glorioso | University of Pittsburgh at Pittsburgh | Conflict of Interest | Oncorus | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.